Screener
Royalty Pharma RPRX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on trailing twelve months.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's asset turnover?
- Royalty Pharma (RPRX) reported asset turnover of 0.1× in Q2 2026.
- How has Royalty Pharma's asset turnover changed year-over-year?
- Royalty Pharma's asset turnover increased by 3.8% year-over-year, from 0.1× to 0.1×.
- What is the long-term trend for Royalty Pharma's asset turnover?
- Over 5 years (2020 to 2025), Royalty Pharma's asset turnover has grown at a -3.4% compound annual growth rate (CAGR), from 0.1× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Royalty Pharma's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude